Moreover, the level of EZH2 was gradually increased in breast cancer progression scenarios ranging from normal epithelium to epithelial hyperplasia, DCIS, IDC, and distant metastasis; and the expression of EZH2 was an independent predictor of breast cancer recurrence (119). This evidence concerns the gene EZH2 and breast carcinoma.